Condition
Nodule Solitary Pulmonary
Total Trials
6
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Active Not Recruiting1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04171492Active Not RecruitingPrimary
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
NCT03774758RecruitingPrimary
Biomarkers for Risk Stratification in Lung Cancer
NCT03766958CompletedPrimary
A Registry to Evaluate the Performance of the BDX-XL2 Test
NCT04168359Not ApplicableCompleted
Semi-barbed Suture for Pulmonary Small Nodules Localization
NCT02952066Not ApplicableWithdrawn
Expressions of TRPV1 in Airway of Asthmatics
NCT03439696Not ApplicableCompleted
Needlescopic-assisted Uniportal vs Uniportal VATS
Showing all 6 trials